Patient Square Capital as of June 30, 2026
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 23 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 44.0 | $284M | 8.0M | 35.39 | |
| Revolution Medicines (RVMD) | 8.0 | $52M | 276k | 187.28 | |
| Mirum Pharmaceuticals (MIRM) | 4.7 | $31M | 261k | 117.07 | |
| Abivax Sa Sponsored Ads (ABVX) | 4.3 | $28M | 207k | 133.26 | |
| Beone Medicines Sponsored Ads (ONC) | 4.0 | $26M | 90k | 284.97 | |
| Pharvaris N V (PHVS) | 3.6 | $23M | 671k | 34.58 | |
| Argenx Se Sponsored Adr (ARGX) | 3.3 | $21M | 23k | 927.77 | |
| United Therapeutics Corporation (UTHR) | 3.1 | $20M | 37k | 541.83 | |
| Belite Bio Sponsored Ads (BLTE) | 2.6 | $17M | 110k | 153.99 | |
| Cogent Biosciences (COGT) | 2.5 | $16M | 425k | 38.70 | |
| Dbv Technologies S A Sponsored Ads (DBVT) | 2.3 | $15M | 910k | 16.40 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $13M | 220k | 60.36 | |
| Biontech Se Sponsored Ads (BNTX) | 1.9 | $13M | 134k | 93.05 | |
| Arcus Biosciences Incorporated (RCUS) | 1.7 | $11M | 356k | 30.83 | |
| Enliven Therapeutics (ELVN) | 1.7 | $11M | 213k | 50.75 | |
| Dianthus Therapeutics (DNTH) | 1.6 | $11M | 108k | 97.48 | |
| Allogene Therapeutics (ALLO) | 1.6 | $11M | 5.1M | 2.08 | |
| Eyepoint Com New (EYPT) | 1.6 | $10M | 720k | 14.30 | |
| Arcutis Biotherapeutics (ARQT) | 1.5 | $9.7M | 370k | 26.22 | |
| C4 Therapeutics Com Stk (CCCC) | 1.2 | $7.5M | 1.6M | 4.67 | |
| Inventiva Sa Ads (IVA) | 1.2 | $7.4M | 2.0M | 3.78 | |
| Kymera Therapeutics (KYMR) | 0.8 | $5.4M | 48k | 114.67 | |
| Faeth Therapeutics Com New (FTH) | 0.7 | $4.4M | 175k | 25.00 |
